Transaction DateRecipientSharesTypePriceValue
14th August 2020Earl W Brien150,000Exercise of derivative$0.26$39,000.00
7th August 2020Steven A Kriegsman3,000,000Exercise of derivative$0.26$780,000.00
7th August 2020Steven A Kriegsman1,164,179Payment by withholding$0.67$779,999.93
7th August 2020Louis Ignarro700,000Exercise of derivative$0.26$182,000.00
7th August 2020Louis Ignarro271,642Payment by withholding$0.67$182,000.14
7th August 2020Joel K Caldwell450,000Exercise of derivative$0.26$117,000.00
7th August 2020Joel K Caldwell174,627Payment by withholding$0.67$117,000.09
Cyt Rx Corporation
Cyt Rx Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


CytRx Corp. is a biopharmaceutical research and development company. It focuses on developing novel anti-cancer drug candidates. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.


Ticker: CYTR
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 799698
Employees: 6
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals